Dementia Therapeutics Market Pipeline Review, H2 2017
“Pharmaceutical and Healthcare disease pipeline guide Dementia - Pipeline
Review, H2 2017, provides an overview of the Dementia (Central Nervous
System) pipeline landscape.”
Summary
Pharmaceutical and Healthcare disease pipeline guide Dementia - Pipeline Review, H2 2017, provides an
overview of the Dementia (Central Nervous System) pipeline landscape.
Dementia is the loss of mental functions such as thinking, memory, and reasoning that is severe enough to
interfere with a person's daily functioning. Symptoms include memory loss, hallucinations, agitation,
personality changes and difficulty with coordination and motor functions. Risk factors include age, smoking,
obesity, high blood pressure, inflammation and cardiovascular diseases.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Dementia - Pipeline Review, H2 2017, provides
comprehensive information on the therapeutics under development for Dementia (Central Nervous System),
complete with analysis by stage of development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and latest news and press releases.
Browse Detail Report With TOC @
https://www.hexareports.com/report/dementia-pipeline-review-h2-2017
Follow Us: